MedStar Washington Hospital Center is the largest private hospital in Washington, D.C. A member of MedStar Health, the not-for-profit Hospital Center is licensed for 926 beds. Health services in primary, secondary and tertiary care are offered to adult and neonatal patients.

There are 912 beds in MedStar Washington Hospital Center.

During the past decade, MedStar Washington Hospital Center conducted 314 clinical trials. In the 10-year time frame, 314 clinical trials started and 212 clinical trials were completed, i.e. on average, 67.5% percent of trials that started reached the finish line to date. In the past 5 years, 134 clinical trials started and 121 clinical trials were completed. i.e. 90.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MedStar Washington Hospital Center" #1 sponsor was "Medstar Health Research Institute" with 87 trials, followed by "National Cancer Institute (NCI)" with 63 trials sponsored, "Abbott Medical Devices" with 33 trials sponsored, "Boston Scientific Corporation" with 28 trials sponsored and "Alliance for Clinical Trials in Oncology" with 28 trials sponsored. Other sponsors include 389 different institutions and companies that sponsored additional 224 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MedStar Washington Hospital Center" #1 collaborator was "National Cancer Institute (NCI)" with 53 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Medstar Health Research Institute" with 15 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 10 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator. Other collaborators include 343 different institutions and companies that were collaborators in the rest 229 trials.

According to Clinical.Site data, the most researched conditions in "MedStar Washington Hospital Center" are "Coronary Artery Disease" (38 trials), "Heart Failure" (23 trials), "Breast Cancer" (21 trials), "Stroke" (20 trials) and "Atrial Fibrillation" (19 trials). Many other conditions were trialed in "MedStar Washington Hospital Center" in a lesser frequency.

Most popular intervention types in "MedStar Washington Hospital Center" are "Drug" (260 trials), "Device" (216 trials), "Other" (138 trials), "Biological" (69 trials) and "Procedure" (61 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (39 trials), "Paclitaxel" (24 trials) and "Carboplatin" (21 trials). Other intervention names were less common.

The vast majority of trials in "MedStar Washington Hospital Center" are 518 trials for "All" genders, 91 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 213 active trials in "MedStar Washington Hospital Center". 2 are not yet recruiting, 93 are recruiting, 112 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 318 completed trials in MedStar Washington Hospital Center, undefined suspended trials, and 57 terminated clinical trials to date.

Out of the total trials that were conducted in MedStar Washington Hospital Center, 14 "Phase 1" clinical trials were conducted, 117 "Phase 2" clinical trials and 168 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 32 trials, and there were also 205 trials that are defined as “Not Applicable".